Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 7 Neoplasms 2 Weight Loss 1 Prostatic Neoplasms 1 Polyps 1 Osteoporosis 1 Myocardial Ischemia 1 Myocardial Infarction 1 Metabolic Syndrome 1 Heart Diseases 1 Diabetes Mellitus 1 Depression 1 Coronary Disease 1 Colonic Neoplasms 1 Cognitive Dysfunction 1 Cardiovascular Diseases 1 Carcinoma, Renal Cell 1 Bone Diseases 1 Body Weight Changes 1 Angina, Unstable 1 Adenoma 1

Interventions

Exercise 6 Diet 6 Octreotide 3 Metformin 3 Caloric Restriction 3 Diet, Carbohydrate-Restricted 2 Cognitive Behavioral Therapy 2 sibutramine 1 remune 1 olanzapine-fluoxetine combination 1 irinotecan sucrosofate 1 bermekimab 1 Weight Reduction Programs 1 TOPS 1 Surveys and Questionnaires 1 Sugars 1 Standard of Care 1 Sampling Studies 1 Ritonavir 1 Resistance Training 1 Quality of Life 1 Psychology, Positive 1 Palonosetron 1 Palliative Care 1 Olanzapine 1 Nutritionists 1 Nutritional Status 1 Nutrition Assessment 1 Methods 1 Melatonin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Weight Loss × Diet, Fat-Restricted × Clear all

NCT01559194 2014-04-14

LEAF

Ohio State University Comprehensive Cancer Center

Phase 3 Completed

Breast Neoplasms, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon ⚡